# MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

> **NCT03053193** · — · RECRUITING · sponsor: **Agendia** · enrollment: 30000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MammaPrint, BluePrint, and Full-Genome Testing

## Key facts

- **NCT ID:** NCT03053193
- **Lead sponsor:** Agendia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-04-28
- **Primary completion:** 2037-04
- **Final completion:** 2037-12
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053193, "MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03053193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*